Novel neuroprotective action of prothymosin alpha‐derived peptide against retinal and brain ischemic damages

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Neurochemistry

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jnc.12132PMID 23278181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-Penetrating Peptides.

  2021cited by this paper
• Ischemic Cerebral Damage: An Appraisal of Synaptic Failure

  2012cited by this paper
• Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia.

  2012cited by this paper
• Prothymosin α plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms

  2012cited by this paper
• Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond

  2012cited by this paper
• Neuron‐specific non‐classical release of prothymosin alpha: a novel neuroprotective damage‐associated molecular patterns

  2012cited by this paper
• Prothymosin-α Interacts with Mutant Huntingtin and Suppresses Its Cytotoxicity in Cell Culture*

  2011influential reference
• Acute retinal necrosis associated optic neuropathy

  2011cited by this paper
• Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats.

  2011cited by this paper
• The immunology of stroke: from mechanisms to translation

  2011cited by this paper
• [Molecular mechanisms of retinal ischemia].

  2010cited by this paper
• Retinal gene expression after central retinal artery ligation: effects of ischemia and reperfusion.

  2010cited by this paper
• miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia.

  2010cited by this paper
• Prothymosin α as robustness molecule against ischemic stress to brain and retina

  2010cited by this paper
• Genetics of stroke

  2010cited by this paper
• Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury

  2010cited by this paper
• Cell-death-mode switch from necrosis to apoptosis in hydrogen peroxide treated macrophages

  2010cited by this paper
• Prothymosin-α inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction

  2010cited by this paper
• Thymosin α1: the regulator of regulators?

  2010cited by this paper
• Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage

  2010cited by this paper
• Mitochondria, oxidative metabolism and cell death in stroke.

  2010cited by this paper
• Prothymosin-α plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition

  2009influential reference
• Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner.

  2009cited by this paper
• From lab to bedside: emerging clinical applications of thymosin α1

  2009cited by this paper
• Genetics of stroke

  2009cited by this paper
• Angiogenesis after cerebral ischemia

  2009cited by this paper
• Microglial Involvement in Neuroplastic Changes Following Focal Brain Ischemia in Rats

  2009cited by this paper
• From lab to bedside: emerging clinical applications of thymosin alpha 1.

  2009cited by this paper
• The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischaemia studies

  2009cited by this paper
• Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage.

  2009cited by this paper
• Prothymosin α plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke

  2008cited by this paper
• The cost of cerebral ischaemia.

  2008cited by this paper
• Up‐regulation of brain‐derived neurotrophic factor by application of fibroblast growth factor‐2 to the cut optic nerve is important for long‐term survival of retinal ganglion cells

  2008cited by this paper
• Progressive Ganglion Cell Degeneration Precedes Neuronal Loss in a Mouse Model of Glaucoma

  2008cited by this paper
• Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa.

  2007cited by this paper
• Identification of prothymosin-α1, the necrosis–apoptosis switch molecule in cortical neuronal cultures

  2007cited by this paper
• Proteomic exploitation on prothymosin α‐induced mononuclear cell activation

  2007cited by this paper
• Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation.

  2007cited by this paper
• Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives

  2007cited by this paper
• Activity-dependent neuroprotective protein: from gene to drug candidate.

  2007cited by this paper
• Prothymosin-α1 prevents necrosis and apoptosis following stroke

  2007influential reference
• Thymosin Alpha 1

  2007cited by this paper
• Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models.

  2007cited by this paper
• Plasminogen activator inhibitor‐1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice

  2007cited by this paper
• Prothymosin-alpha1 prevents necrosis and apoptosis following stroke.

  2007influential reference
• Screening for peptide drugs from the natural repertoire of biodiverse protein folds

  2006cited by this paper
• Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina

  2006cited by this paper
• Nuclear Oncoprotein Prothymosin α Is a Partner of Keap1: Implications for Expression of Oxidative Stress-Protecting Genes

  2005cited by this paper
• Stroke epidemiology in the developing world.

  2005cited by this paper
• Cell death mode switch from necrosis to apoptosis in brain.

  2004cited by this paper
• Erythropoietin in the brain: can the promise to protect be fulfilled?

  2004cited by this paper
• Retinal ischemia: mechanisms of damage and potential therapeutic strategies.

  2004cited by this paper
• Relationships between the electroretinogram a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis

  2004cited by this paper
• Protein‐protein interactions as a target for drugs in proteomics

  2003cited by this paper
• Functional Outcome of Ischemic and Hemorrhagic Stroke Patients After Inpatient Rehabilitation: A Matched Comparison

  2003cited by this paper
• Protein kinase C-mediated cell death mode switch induced by high glucose

  2003cited by this paper
• Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.

  2003influential reference
• Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway

  2003cited by this paper
• Fibroblast Growth Factor 2 Is Necessary for the Growth of Glutamate Projection Neurons in the Anterior Neocortex

  2002cited by this paper
• Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

  2001cited by this paper
• Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke

  2001cited by this paper
• Brain ischemia and reperfusion: molecular mechanisms of neuronal injury.

  2000cited by this paper
• Functional outcome of ischemic and hemorrhagic stroke patients after inpatient rehabilitation: A matched comparison

  1994cited by this paper
• Plasminogen activator

  1988cited by this paper

• Lumbosacral spinal proteomic changes during PAR4-induced persistent bladder pain.

  2023cites this paper
• Prothymosin α-derived hexapeptide prevents the brain damage and sequelae due to ischemia-hemorrhage.

  2022cites this paper
• Discovery of Antitumor Active Peptides Derived from Peroxiredoxin 5

  2021cites this paper
• Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice.

  2020cites this paper
• Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator‐induced brain damage following cerebral ischemia

  2020cites this paper
• Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury

  2020cites this paper
• Gγ7-specific prothymosin alpha deletion causes stress- and age-dependent motor dysfunction and anxiety.

  2019cites this paper
• [Lysophosphatidic Acid Receptor Signaling Underlying Chronic Pain and Neuroprotective Mechanisms through Prothymosin α].

  2019cites this paper
• Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice

  2018cites this paper
• Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases

  2018cites this paper
• Neuroprotective Agents: An Overview on the General Modes of Action

  2017cites this paper
• MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment

  2017cites this paper
• Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia-reperfusion.

  2016influential citation
• Retinal Cell Degeneration in Animal Models

  2016cites this paper
• Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System.

  2015cites this paper
• Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.

  2015cites this paper
• Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies

  2015cites this paper
• Effects of a conventional photocoagulator and a 3-ns pulse laser on preconditioning responses and retinal ganglion cell survival after optic nerve crush.

  2014cites this paper
• Efeito protetor da flavana extraída da espécie Brosimum acutifolium contra danos causados por hipóxia em células retinianas: um estudo in vitro

  2014cites this paper
• Characterization of rat retinal responses to a conventional retinal laser and a novel short pulse duration laser.

  2014cites this paper
• Therapeutic benefits of 9-amino acid peptide derived from prothymosin alpha against ischemic damages.

  2013cites this paper
• Retinal cell type‐specific prevention of ischemia‐induced damages by LPS‐TLR4 signaling through microglia

  2013cites this paper